scispace - formally typeset
Open AccessJournal ArticleDOI

Understanding and managing acute encephalitis.

Rashmi Kumar
- 29 Jan 2020 - 
- Vol. 9, pp 60
Reads0
Chats0
TLDR
The most important infectious cause in the West is herpes simplex virus, but globally Japanese encephalitis (JE) remains the single largest cause and various forms of immunotherapy are used for AIE.
Abstract
Encephalitis is an important cause of morbidity, mortality, and permanent neurologic sequelae  globally. Causes are diverse and include viral and non-viral infections of the brain as well as autoimmune processes. In the West, the autoimmune encephalitides are now more common than any single infectious cause, but, in Asia, infectious causes are still more common. In 2006, the World Health Organization coined the term “acute encephalitis syndrome”, which simply means acute onset of fever with convulsions or altered consciousness or both. In 2013, the International Encephalitis Consortium set criteria for diagnosis of encephalitis on basis of clinical and laboratory features. The most important infectious cause in the West is herpes simplex virus, but globally Japanese encephalitis (JE) remains the single largest cause. Etiologic diagnosis is difficult because of the large number of agents that can cause encephalitis. Also, the responsible virus may be detectable only in the brain and is either absent or transiently found in blood or cerebrospinal fluid (CSF). Virological diagnosis is complex, expensive, and time-consuming. Different centres could make their own algorithms for investigation in accordance with the local etiologic scenarios. Magnetic resonance imaging (MRI) and electroencephalography are specific for few agents. Clinically, severity may vary widely. A severe case may manifest with fever, convulsions, coma, neurologic deficits, and death. Autoimmune encephalitis (AIE)  includes two major categories: (i) classic paraneoplastic limbic encephalitis (LE) with autoantibodies against intracellular neuronal antigens (Eg: Hu and Ma2) and (ii) new-type AIE with autoantibodies to neuronal surface or synaptic antigens (Eg: anti-N-methyl-D-aspartate receptor). AIE has prominent psychiatric manifestations: psychosis, aggression, mutism, memory loss, euphoria, or fear. Seizures, cognitive decline, coma, and abnormal movements are common. Symptoms may fluctuate rapidly. Treatment is largely supportive. Specific treatment is available for herpesvirus group and non-viral infections. Various forms of immunotherapy are used for AIE.

read more

Citations
More filters
Journal ArticleDOI

Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.

TL;DR: In this article, the first dose of mRNA-1273 vaccine from Moderna was administered to a patient with mild fever, generalised rash, confusion, orofacial movements and myoclonus.
Journal ArticleDOI

Global magnitude of encephalitis burden and its evolving pattern over the past 30 years.

TL;DR: In this article , the authors estimate the spatiotemporal patterns of the encephalitis burden along with its attributable risk factors at the national, regional, and global levels, which may be helpful in guiding targeted prevention and treatment programs.
Journal ArticleDOI

An atypical case of febrile infection-related epilepsy syndrome following acute encephalitis: impact of physiotherapy in regaining locomotor abilities in a patient with neuroregression.

TL;DR: The physiotherapy interventions including neurodevelopmental treatment (NDT) and sensory integration (SI) helped in regaining locomotion ability in the child, who presented with difficulty to maintain sitting posture, and inability to stand and walk without support following viral encephalitis.
Journal ArticleDOI

Glutamate Chemical Exchange Saturation Transfer (GluCEST) Magnetic Resonance Imaging in Pre-clinical and Clinical Applications for Encephalitis.

TL;DR: GluCEST will provide new insight into encephalitis and help improve the differential diagnosis of brain disorders and the GluC EST imaging signal has potential as an in vivo imaging biomarker for the early diagnosis ofEncephalitis.
Journal ArticleDOI

Encephalitis: diagnosis, management and recent advances in the field of encephalitides

TL;DR: The causes, clinical manifestations and management of encephalitis are reviewed and recent advances and challenges of research into encephalitic syndromes are integrated.
References
More filters
Journal ArticleDOI

Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma

TL;DR: The autoantigens of a new category of treatment‐responsive paraneoplastic encephalitis are reported, and it is proposed that this category should be combined with existing treatment-responsive encephalopathy categories.
Journal ArticleDOI

The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America

TL;DR: The guideline includes data on the epidemiology, clinical features, diagnosis, and treatment of many viral, bacterial, fungal, protozoal, and helminthic etiologies of encephalitis and provides information on when specific etiologic agents should be considered in individual patients with encephalopathy.
Journal ArticleDOI

Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium

TL;DR: A consensus document is presented that proposes a standardized case definition and diagnostic guidelines for evaluation of adults and children with suspected encephalitis and will serve as a practical aid to clinicians evaluating patients with suspectedEncephalitis.
Journal ArticleDOI

Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis

TL;DR: The recognition of discrete clinical profiles among patients with encephalitis should help focus efforts toward understanding the etiology, pathogenesis, course, and management of this complex syndrome.